Ratings
0
Nobody has rated this yet. Be the first!
Works
3
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma.
